Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX- Colorectal Cancer (CRC) Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Dec 2018
At a glance
- Drugs Avelumab (Primary) ; Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms AVETUX
- Sponsors AIO Studien gGmbH
- 24 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated
- 05 Jun 2018 Interim safety run-in phase analysis results (n=24) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.